Provided by Tiger Fintech (Singapore) Pte. Ltd.

COEPTIS THERAPEUTICS HOLDINGS INC

8.75
-0.2000-2.23%
Volume:31.45K
Turnover:274.91K
Market Cap:30.75M
PE:-1.99
High:8.99
Open:8.99
Low:8.63
Close:8.95
Loading ...

Coeptis Nexgenai Affiliates Network & Marketleverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing

THOMSON REUTERS
·
20 Feb

Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation

Insider Monkey
·
14 Feb

BRIEF-COEPTIS Announces The Launch Of COEP Venture Group To Invest In AI, RPA, And AI Agent Startups

Reuters
·
13 Feb

Coeptis Announces the Launch of Coep Venture Group to Invest in AI, Rpa, and AI Agent Startups

THOMSON REUTERS
·
13 Feb

COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups

GlobeNewswire
·
13 Feb

Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations

Insider Monkey
·
08 Feb

Coeptis Completes $10 Million Series a Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

THOMSON REUTERS
·
06 Feb

Press Release: COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

Dow Jones
·
06 Feb

Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation

Insider Monkey
·
31 Jan

Coeptis Therapeutics Holdings: Rebrands to Coeptis

THOMSON REUTERS
·
30 Jan

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation

PR Newswire
·
30 Jan

Coeptis Therapeutics Holdings Inc trading resumes

TIPRANKS
·
23 Jan

Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause

TIPRANKS
·
23 Jan

Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation

PR Newswire
·
23 Jan

BRIEF-Coeptis Therapeutics Regains Compliance With Nasdaq Listing

Reuters
·
22 Jan

Coeptis Therapeutics Regains Compliance With Nasdaq Listing Rule 5550(a)(2)

THOMSON REUTERS
·
22 Jan

Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

PR Newswire
·
22 Jan

Coeptis Therapeutics Holdings Inc Files For Resale Of Up To 3.92 Million Shares By The Selling Stockholders - SEC Filing

Reuters
·
11 Jan

Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform

PR Newswire
·
07 Jan

Coeptis Therapeutics Holdings Inc trading resumes

TIPRANKS
·
07 Jan